Skip to content

Effect OF Gokshuradi Guggulu And Punarnavasava In Shoth Roga (Nephrotic Syndrome)

Add On Efficacy Of Gokshuradi Guggulu And Punarnavasava In Shoth Roga (Nephrotic Syndrome)- A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065423
Enrollment
72
Registered
2024-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N040- Nephrotic syndrome with minor glomerular abnormality

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient meeting the criteria of Nephrotic Syndrome N04.0 as mentioned in ICD-10 classification. Patients of Idiopathic Nephrotic Syndrome (diagnostic criteria as per Indian Society of Pediatric Nephrology (ISPN) 2021 guideline. Patients diagnosed with Steroid Sensitive Nephrotic Syndrome. Pediatric population 6-16 years of age irrespective of the sex. Written informed consent obtained from the subject’s parents/guardians and written assent obtained from subject (where age appropriate).

Exclusion criteria

Exclusion criteria: Patient less than 6 or more than 16 years of age Patient suffering from steroid resistant nephrotic syndrome Patients diagnosed with nephritic syndrome or IgA nephropathy. Patient suffering from ascites, pleural effusion and pericardial effusion. Patients suffering from serious infections such as pyelonephritis, pneumonia, any other respiratory infections.

Design outcomes

Primary

MeasureTime frame
Reduction in the frequency of relapse.Timepoint: 30th, 60th and 90th day

Secondary

MeasureTime frame
1.Change in the biochemical parameters Sr. Albumin, Sr. Cholesterol, Urine analysis, Up/Uc. 2. Alterations in the cumulative dose of prednisolone. 3. Reduction in the episode of recurrent urinary or respiratory tract infections. Timepoint: 1. Baseline 0th Day, 30th Day, 60th Day & 120th Day

Countries

India

Contacts

Public ContactDr Prashant Kumar Gupta

All India Institute of Ayurveda

ayuarun@gmail.com8506821947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026